Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli

NCT00300560 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT00300560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00300560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Colistin for Therapy of Infections Caused by Extended Spectrum Beta-Lactamase(ESBL) Producing Klebsiella Pneumoniae or Escherichia Coli
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2006
Completion date
December 31, 2006
Enrollment
152
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections